Results 321 to 330 of about 306,241 (411)

Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review

open access: yesClinical Oral Implants Research, EarlyView.
ABSTRACT Objectives The aim of this scoping review is to determine the effects of autoimmune diseases (ADs) and the agents used for treatment on dental implant survival and biologic outcomes. Material and Methods An electronic database search was performed in MEDLINE (PubMed), The Cochrane Library, and Embase on 29‐04‐2024.
Emil Hyldahl   +2 more
wiley   +1 more source

Dental pathology in chinchillas [PDF]

open access: yes, 2010
Derbaudrenghien, Virginie   +4 more
core  

Stratum Corneum Interleukin‐2 in Facial Eczema at 1‐Month‐Old Predicts Later Atopic Dermatitis

open access: yes
Allergy, EarlyView.
Eriko Maehara   +14 more
wiley   +1 more source

An evaluation of important plant areas around the world

open access: yesConservation Biology, EarlyView.
Abstract Area‐based approaches have long dominated biodiversity conservation and have been reinforced by the Kunming–Montreal Global Biodiversity Framework. The important plant area (IPA) approach is a leading framework for the spatial conservation prioritization of plants and fungi, but over 20 years since its launch, its application and conservation ...
Laura Kor   +4 more
wiley   +1 more source

Pleomorphic Adenoma of the Cheek : Report of a Case

open access: bronze, 1982
Hideo Kurokawa   +5 more
openalex   +2 more sources

Risk Factors for Ectropion After Lower Eyelid and Cheek Reconstruction Following Mohs Micrographic Surgery. [PDF]

open access: yesPlast Reconstr Surg Glob Open
Rames JD   +8 more
europepmc   +1 more source

A case report of neurilemmoma occurring in the region from the cheek to the pterygopalatine fossa

open access: bronze, 1989
Noboru Hayashi   +7 more
openalex   +2 more sources

Social‐benefits stigma and subsequent competitiveness

open access: yesEconomic Inquiry, EarlyView.
Abstract We conduct a laboratory experiment to explore how benefit‐eligibility stigma drives subsequent decisions to enter competition. We induce a stigma associated with a low‐status benefit and then introduce “plausible deniability” to reduce this stigma by expanding benefit eligibility to a middle‐status group.
Natalia I. Valdez Gonzalez   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy